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1. Introduction 
Several chemically unrelated rugs stimulate the hepatic 
formation of porphyrins in the whole animal and in 
liver cells cultured in vitro [ 1,2] and enchance the ac- 
tivity of &aminolaevulic acid (&ALA) synthetase, the 
rate-limiting enzyme in the biosynthetic pathway of 
porphyrins and haem [3] . This is thought o result from 
an interference by the drugs with the feed-back control 
exercised by haem at the level of the enzyme [3], al- 
though the exact mechanism of this effect is not known. 
One of these drugs, 2-allyl-2-isopropylacetamide (AIA), 
causes arapid decrease in the level of cytochrome P-450 
and haem in rat liver microsomes. This effect, which 
apparently requires the activity of drug-metabolizing 
enzymes in liver microsomes, isdue to a loss of existing 
cytochrome P-450 and haem rather than an inhibition 
of their synthesis. Evidence has also been obtained that 
the haem lost undergoes a change in chemical constitu- 
tion, probably to certain illdefmed green pigments al- 
ready described in the liver of animals with experimental 
porphyria. 
2. Experimental 
Male albino rats (150- 180 g) of the Porton strain 
were fasted for twenty four hours before being injected 
with AIA (20 mg/ml of 09% NaCl) in the loose sub- 
cutaneous tissue of the neck. In some experiments, the 
animals were treated with phenobarbitone orSKF-525A 
(2diethylaminoethyl diphenyl-propylacetate) before 
administration of AIA, as already described [4]. The 
North-Holland Publishing Company - Amsterdam 
methods followed for the preparation of liver micro- 
somes and for the estimation of microsomal cyto- 
chromes have also been described [4]. 
3. Results and discussion 
The effect of a single subcutaneous injection of AIA 
on the level of cytochrome P-450 in the liver micro- 
somes of the rat is shown in fig. 1. The changes in ao 
tivity of &ALA synthetase observed by Marver et al. 
[5] with the same dose of drug are shown in the same 
figure for comparison. Cytochrome levels and enzyme 
activity behaved in a reciprocal fashion; one hour after 
administration of the drug, a fall in cytochrome level 
was already apparent, while the enzyme activity began 
to rise; at forty eight hours, the a-ALA synthetase ao 
tivity had returned to normal, and the cytochrome 
level had risen above its initial value. 
A decline in P-450 levels following administration 
of AIA has already been described by Wada et al. [6] 
and by Waterfield et al. [7] in mice and rabbits, res- 
pectively. No attempt was made by these authors to 
establish whether the decrease was due to inhibition 
of haem and (or) of cytochrome synthesis, or to loss 
of existing pigment: Wada et al. [6] suggested that 
inhibition of haem synthesis was the mechanism in- 
volved. Comparison of the rate or P-450 decline ob- 
served in normal animals (fig. 1) or in phenobarbitone- 
induced animals (see below) with that obtained after 
nearly complete inhibition of protein synthesis by cy- 
cloheximide [4] indicated, however, that loss of 
existing pigment was more likely. More direct evidence 
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Fig. 1. The effect of a single subcutaneous injection of AIA 
(400 mg/kg) on microsomalP-450 levels (a- i- 0) aird S-ALA 
synthetase activity of the liver homogenate ( -). P-450 
levels are given as avergae (+S.E.) of the values observed in 
four animals. The data on &ALA synthetase activity are from 
Marver’s work [ 51. 
for an increased estruction of P-450 and haem fol- 
lowing administration of AIA is given below. 
The decline in cytochrome P-450 caused by AIA 
was affected by treatment known to alter the activity 
of the microsomal drug-metabolizing enzymes. Pre- 
treatment of rats with phenobarbitone which stimulates 
drug metabolism in the liver microsomes, greatly in- 
creased the loss of P-450 caused by AIA, whereas 
SKF-525A, an inhibitor of drug-metabolizing enzymes 
afforded protection. Percentage losses of P-450 caused 
by AIA (as compared with appropriate controls) were 
as follows (with time between drug administration and 
killing in parentheses): normal animal: 2% (1 hr); 
57% (5 hr); Rats given SKF525A before AIA: 12% 
(5 hr); Phenobarbitone-induced rats: 70% (1 hr). 
SKF-S25A also partially reversed the increased loss of 
P-450 observed after phenobarbitone treatment. These 
findings uggested that AIA must be metabolized by 
the liver microsomes in order to produce its effect on 
P-450. Results compatible with this interpretation 
were obtained in experiments in vitro. When liver 
microsomes from phenobarbitone-induced rats were 
incubated with AIA, a loss of cytochrome P-450 was 
observed only when NADPH, the cofactor essential 
for metabolism of drugs by the liver microsomes, was 
also present. Some loss of P-450 was also observed 
when the microsomes were incubated in the presence 
of NADPH, but with no AIA. 
In contrast with the marked loss of cytochrome 
P-450 observed after administration of AIA to pheno- 
barbitone-treated rats, the cytochrome b5 and protein 
content of the microsomes and the glucosed-phospha- 
tase activity of the liver were only slightly decreased. 
The fall in cytochrome P-450 level was accompanied 
by a loss of microsomal haem and by a characteristic 
brown-green discolouration of the whole liver, parti- 
cularly the microsomes. Both loss of haem and degree 
of discolouration appeared to be related to rate and 
extent of P-450 loss; they were more pronounced in 
phenobarbitone-treated animals than in normal animals 
and much less apparent in rats given SKF-525A before 
AIA. Microsomes incubated with AIA and NADIR 
were also discoloured at the end of incubation, where- 
as those incubated with AIA alone were not. 
Schwartz and Ikeda [8] &scribed a discolouration 
of the liver of rats and rabbits given either AIA or the 
related rug Sedormid and they extracted and partially 
characterized certain green pigments responsible for 
this abnormal colour. The significance of these pig- 
ments remained obscure. The present results suggest 
that the abnormal pigments might arise from some 
chemical change in existing haem as a result of the 
action of AIA on liver microsomes. To investigate 
this, the liver haems of phenobarbitone-induced rats 
were pre-labelled with radioactive S-ALA prior to AIA 
administration and the distribution of the label be- 
tween haem and the fractions known to contain the 
green pigments [9] was studied, in treated and control 
rats. Animals killed one hour after AIA administration 
showed a considerable oss of radioactivity in the haem 
isolated from their liver homogenates, while a corre- 
ponding increase in the radioactivity was recovered in 
the green pigments fractions [lo] . The exact nature 
of these pigments and the mechanism by which they 
are produced from haem under the influence of AIA 
are being investigated. One possibility is that AIA 
might damage the microsomal structure so that labile 
pools of microsomal haem (such as the P-450 haem) 
become sensitive to random methine bridge oxidation 
by endogenously occurring oxidants, such as ascorbate; 
similarly to the ascorbatecatalysed breakdown of haem 
in vitro [ 1 l] , this would give rise to a mixture of pre- 
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dominantly nonphysiological biliverdin isomers, which 
would not be converted to bilirubin [ 121 and would 
tend to accumulate in the liver. Alternatively, the stru- 
ture of haem may be altered by peroxides produced 
during the metabolism of the drug or by some reactive 
metabolite of the drug itself. 
The significance of the loss of haem caused by AIA 
in relation to the induction of S-ALA synthetase can- 
not be conclusively assessed atthe moment. However, 
the present results raise the possibility that a drug or 
an active principle produced uring its metabolism 
may, by changing the chemical constitution of haem, 
render it unable to fulfil its normal function of feed- 
back control at the level of S-ALA synthetase. 
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